Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses—potential clinical implications

Rakesh Sindhi(Boston Children's Hospital), Jan Allaert(Becton Dickinson (United States)), Daiva Gladding(Becton Dickinson (United States)), Perry Haaland(Becton Dickinson (United States)), Bruce Koppelman(Becton Dickinson (United States)), John F. Dunne(Becton Dickinson (United States)), Suren N. Sehgal

Journal of Immunological Methods

January 1, 2003

10.1016/s0022-1759(02)00326-5

Cited by 20

Abstract

Related Papers

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Jun S. Liu, Jesse D. Farmer, Willam S. Lane et al.|Cell|1991|4.1k

Detection of intracellular cytokines by flow cytometry

Thomas Jung, Suzanne Schuh, Christoph Heusser et al.|Journal of Immunological Methods|1993|988

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

Barry D. Kahan|The Lancet|2000|917

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

Suren N. Sehgal|Clinical Biochemistry|1998|663

A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS

Allan S. MacDonald|Transplantation|2001|622